Donald B. Stedman

990 total citations
28 papers, 602 citations indexed

About

Donald B. Stedman is a scholar working on Molecular Biology, Biomedical Engineering and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Donald B. Stedman has authored 28 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Biomedical Engineering and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Donald B. Stedman's work include 3D Printing in Biomedical Research (8 papers), Pluripotent Stem Cells Research (7 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Donald B. Stedman is often cited by papers focused on 3D Printing in Biomedical Research (8 papers), Pluripotent Stem Cells Research (7 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Donald B. Stedman collaborates with scholars based in United States, Sweden and United Kingdom. Donald B. Stedman's co-authors include Frank Welsch, Robert E. Chapin, Steven W. Kumpf, Randal D. Streck, Barbara A. Elswick, Yvonne Will, Michael D. Aleo, Ketti K. Terry, Jedd Hillegass and Malcolm J. Hetheridge and has published in prestigious journals such as Environmental Health Perspectives, Journal of Medicinal Chemistry and Experimental Cell Research.

In The Last Decade

Donald B. Stedman

28 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald B. Stedman United States 14 301 152 108 79 72 28 602
Nicole Clemann Switzerland 12 669 2.2× 261 1.7× 252 2.3× 112 1.4× 114 1.6× 20 1.0k
Evan A. Thackaberry United States 14 167 0.6× 139 0.9× 21 0.2× 71 0.9× 18 0.3× 29 574
Edward Dere United States 17 346 1.1× 348 2.3× 25 0.2× 258 3.3× 18 0.3× 32 870
Raegan O’Lone United States 11 336 1.1× 125 0.8× 20 0.2× 177 2.2× 35 0.5× 16 824
Susan Crowell United States 15 162 0.5× 116 0.8× 29 0.3× 104 1.3× 13 0.2× 28 485
Fiona E. Mitchell United Kingdom 10 458 1.5× 169 1.1× 7 0.1× 80 1.0× 24 0.3× 13 765
Kathryn E. Plant United Kingdom 14 292 1.0× 82 0.5× 14 0.1× 76 1.0× 13 0.2× 30 541
Kevin L. Salyers United States 15 176 0.6× 91 0.6× 26 0.2× 59 0.7× 11 0.2× 21 517
Rossella Galati Italy 17 510 1.7× 185 1.2× 26 0.2× 280 3.5× 6 0.1× 38 1.1k
Guoyu Ling United States 11 255 0.8× 31 0.2× 38 0.4× 65 0.8× 4 0.1× 17 527

Countries citing papers authored by Donald B. Stedman

Since Specialization
Citations

This map shows the geographic impact of Donald B. Stedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald B. Stedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald B. Stedman more than expected).

Fields of papers citing papers by Donald B. Stedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald B. Stedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald B. Stedman. The network helps show where Donald B. Stedman may publish in the future.

Co-authorship network of co-authors of Donald B. Stedman

This figure shows the co-authorship network connecting the top 25 collaborators of Donald B. Stedman. A scholar is included among the top collaborators of Donald B. Stedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald B. Stedman. Donald B. Stedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suter‐Dick, Laura, Paula M. Alves, Bas J. Blaauboer, et al.. (2015). Stem Cell-Derived Systems in Toxicology Assessment. Stem Cells and Development. 24(11). 1284–1296. 43 indexed citations
2.
Ball, Jonathan S., Donald B. Stedman, Jedd Hillegass, et al.. (2014). Fishing for Teratogens: A Consortium Effort for a Harmonized Zebrafish Developmental Toxicology Assay. Toxicological Sciences. 139(1). 210–219. 65 indexed citations
3.
Nadanaciva, Sashi, Michael D. Aleo, Christopher J. Strock, et al.. (2013). Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Toxicology and Applied Pharmacology. 272(2). 272–280. 38 indexed citations
4.
Wager, Travis T., Bethany L. Kormos, Yvonne Will, et al.. (2013). Improving the Odds of Success in Drug Discovery: Choosing the Best Compounds for in Vivo Toxicology Studies. Journal of Medicinal Chemistry. 56(23). 9771–9779. 26 indexed citations
5.
Cappon, Gregg D., et al.. (2012). Reproductive Toxicity Assessment of Sunitinib, A Multitargeted Receptor Tyrosine Kinase Inhibitor, in Male and Female Rats. Birth Defects Research Part B Developmental and Reproductive Toxicology. 95(4). 267–275. 12 indexed citations
6.
Johnson, Kjell, et al.. (2011). Not a walk in the park: the ECVAM whole embryo culture model challenged with pharmaceuticals and attempted improvements with random forest design. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(2). 111–121. 8 indexed citations
7.
Knudsen, Thomas B., Robert J. Kavlock, George P. Daston, et al.. (2011). Developmental toxicity testing for safety assessment: new approaches and technologies. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(5). 413–420. 26 indexed citations
8.
Chapin, Robert E. & Donald B. Stedman. (2009). Endless Possibilities: Stem Cells and the Vision for Toxicology Testing in the 21st Century. Toxicological Sciences. 112(1). 17–22. 50 indexed citations
9.
Kumpf, Steven W., et al.. (2008). Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry. Birth Defects Research Part B Developmental and Reproductive Toxicology. 83(2). 104–111. 82 indexed citations
10.
Chapin, Robert E., et al.. (2006). Struggles for equivalence: In vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicology in Vitro. 21(8). 1545–1551. 19 indexed citations
11.
Chaudhary, Khuram W., Nestor X. Barrezueta, Anthony J. Milici, et al.. (2005). Embryonic Stem Cells in Predictive Cardiotoxicity: Laser Capture Microscopy Enables Assay Development. Toxicological Sciences. 90(1). 149–158. 27 indexed citations
12.
Streck, Randal D., et al.. (2003). Rat embryos express transcripts for cyclooxygenase‐1 and carbonic anhydrase‐4, but not for cyclooxygenase‐2, during organogenesis. Birth Defects Research Part B Developmental and Reproductive Toxicology. 68(1). 57–69. 22 indexed citations
13.
Ambroso, Jeffrey L., Donald B. Stedman, Barbara A. Elswick, & Frank Welsch. (1998). Characterization of cell death induced by 2-methoxyethanol in CD-1 mouse embryos on gestation day 8. Teratology. 58(6). 231–240. 10 indexed citations
14.
Ambroso, Jeffrey L., Donald B. Stedman, Barbara A. Elswick, & Frank Welsch. (1998). Characterization of cell death induced by 2‐methoxyethanol in CD‐1 mouse embryos on gestation day 8. Teratology. 58(6). 231–240. 2 indexed citations
15.
Terry, Ketti K., Donald B. Stedman, Brad Bolon, & Frank Welsch. (1996). Effects of 2-methoxyethanol on mouse neurulation. Teratology. 54(5). 219–229. 9 indexed citations
16.
Terry, Ketti K., Barbara A. Elswick, Donald B. Stedman, & Frank Welsch. (1994). Developmental phase alters dosimetry‐teratogenicity relationship for 2‐methoxyethanol in CD‐1 Mice. Teratology. 49(3). 218–227. 31 indexed citations
17.
Mebus, Charles A., David O. Clarke, Donald B. Stedman, & Frank Welsch. (1992). 2-Methoxyethanol metabolism in pregnant CD-1 mice and embryos. Toxicology and Applied Pharmacology. 112(1). 87–94. 13 indexed citations
18.
Boreiko, Craig J., Diane J. Abernethy, Douglas E. Rickert, & Donald B. Stedman. (1989). Effect of growth state, tumor promoters, and transformation upon intercellular communication between C3H/10T1/2 murine fibroblasts. Carcinogenesis. 10(1). 113–121. 11 indexed citations
19.
Welsch, Frank & Donald B. Stedman. (1984). Inhibition of metabolic cooperation between Chinese hamster V79 cells by structurally diverse teratogens. Teratogenesis Carcinogenesis and Mutagenesis. 4(3). 285–301. 31 indexed citations
20.
Gupta, Ramesh C., John E. Thornburg, Donald B. Stedman, & Frank Welsch. (1984). Effect of subchronic administration of methyl parathion on in vivo protein synthesis in pregnant rats and their conceptuses. Toxicology and Applied Pharmacology. 72(3). 457–468. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026